Clinical trials on for 26k volunteers: Bharat Biotech JMD

Bharat Biotech Joint Managing Director Suchitra Ella on Friday said that clinical trials for COVID-19 vaccine Covaxin is running on 26,000 volunteers and the vaccine has been manufactured after hard work of nine months taking care of all the precautions. Ella said that the pharma company has communicated all the information about Covaxin to the experts in order to seek emergency approval for vaccine distribution, adding that no other company even at the international level is at par with us.